Peter Klinke

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Vascular Communications of the Hand in Patients Being Considered for Transradial Coronary Angiography

Michael J. Greenwood, Anthony J. Della-Siega, Eric Fretz et al. · Journal of the American College of Cardiology · 2005 · 87 citations

Transradial Coronary Angiography, Vascular Image, Cardiovascular Disease +11

Systemic Nanoparticle Paclitaxel (<i>nab</i>‐Paclitaxel) for In‐stent Restenosis I (SNAPIST‐I): A First‐in‐Human Safety and Dose‐finding Study

James R. Margolis, John W. McDonald, Richard R. Heuser et al. · Clinical Cardiology · 2007 · 84 citations · Full text

Day procedure intervention is safe and complication free in higher risk patients undergoing transradial angioplasty and stenting. The discharge study

Andrew Small, Peter Klinke, Anthony Della Siega et al. · Catheterization and Cardiovascular Interventions · 2007 · 76 citations

Body Mass Index, Periprocedural Bleeding, and Outcome Following Percutaneous Coronary Intervention (from the British Columbia Cardiac Registry)

Jonathan Byrne, Mark S. Spence, Eric Fretz et al. · The American Journal of Cardiology · 2009 · 56 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Health Policy +13